4//SEC Filing
Klein Katherine J 4
Accession 0001104659-20-078798
CIK 0001082554other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 1:58 PM ET
Size
9.6 KB
Accession
0001104659-20-078798
Insider Transaction Report
Form 4
Klein Katherine J
Director
Transactions
- Award
Stock Options
2020-06-26+5,160→ 5,160 totalExercise: $119.76From: 2021-06-26→ Common Stock (5,160 underlying) - Award
Restricted Stock Units
2020-06-26+1,680→ 1,680 totalExercise: $0.00From: 2021-06-26→ Common Stock (1,680 underlying)
Footnotes (7)
- [F1]Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- [F2]Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the issuer's Annual Meeting of Shareholders.
- [F3]The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
- [F4]The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
- [F5]Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
- [F6]Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
- [F7]Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001625073
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 1:58 PM ET
- Size
- 9.6 KB